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Abstract
Background: Pelvic floor disorders affect almost 50% of aging women. An important role in the
pelvic floor support belongs to the levator ani muscle. The p27/kip1 (p27) protein, multifunctional
cyclin-dependent kinase inhibitor, shows changing expression in differentiating skeletal muscle cells
during development, and relatively high levels of p27 RNA were detected in the normal human
skeletal muscles.
Methods: Biopsy samples of levator ani muscle were obtained from 22 symptomatic patients with
stress urinary incontinence, pelvic organ prolapse, and overlaps (age range 38–74), and nine
asymptomatic women (age 31–49). Cryostat sections were investigated for p27 protein expression
and type I (slow twitch) and type II (fast twitch) fibers.
Results: All fibers exhibited strong plasma membrane (and nuclear) p27 protein expression.
cytoplasmic p27 expression was virtually absent in asymptomatic women. In perimenopausal
symptomatic patients (ages 38–55), muscle fibers showed hypertrophy and moderate cytoplasmic
p27 staining accompanied by diminution of type II fibers. Older symptomatic patients (ages 57–74)
showed cytoplasmic p27 overexpression accompanied by shrinking, cytoplasmic vacuolization and
fragmentation of muscle cells. The plasma membrane and cytoplasmic p27 expression was not
unique to the muscle cells. Under certain circumstances, it was also detected in other cell types
(epithelium of ectocervix and luteal cells).
Conclusions:  This is the first report on the unusual (plasma membrane and cytoplasmic)
expression of p27 protein in normal and abnormal human striated muscle cells in vivo. Our data
indicate that pelvic floor disorders are in perimenopausal patients associated with an appearance
of moderate cytoplasmic p27 expression, accompanying hypertrophy and transition of type II into
type I fibers. The patients in advanced postmenopause show shrinking and fragmentation of muscle
fibers associated with strong cytoplasmic p27 expression.
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Background
Pelvic floor disorders (PFD) are highly prevalent among
elderly women. Many surgical reports attempt to deter-
mine the best surgical treatment for PFD, yet do not ad-
dress the pathophysiology. The etiology of PFD is
probably multifactorial, including a genetic predisposi-
tion to connective tissue abnormalities, vaginal child-
birth with damage to the innervation of the pelvic floor
muscles, estrogen deficiency, and aging effects [1]. The
pelvic floor, situated at the bottom of the abdominal cav-
ity, forms a supporting shelf for the abdominal and pelvic
viscera. It has three layers: the endopelvic fascia, the le-
vator fasciae and muscles, and the perineal membrane/
external anal sphincter.
The primary support for the pelvic organs comes from
the pelvic floor muscles [1,2]. This suggests that an alter-
ation to the levator ani supportive function may signifi-
cantly contribute to the pathogenesis of PFD [3], which
affect 5% of younger and nearly 50% of elderly women
[2]. In women, the levator muscles form a horizontal
shelf with an anterior midline cleft (the urogenital hia-
tus) through which the urethra, vagina, and rectum pass.
Anatomically, the levator muscle is subdivided into the
iliococcygeal and the pubococcygeal muscles [4,5] (Fig.
1).
The levator ani muscles play an important role in bladder
neck fixation provided by the suspensory sling and hiatal
ligament [6]. The urethra is supported by the action of
the levator ani muscles through their connection to the
endopelvic fascia of the anterior vaginal wall [7], and the
muscles of the levator ani contract during a cough to as-
sist continence [8]. The fast twitch type II fibers in the le-
vator ani muscles play an important role in continence,
and their loss accompanies the development of urinary
incontinence [9]. Clinically, women with recurrent uri-
nary incontinence after Burch colposuspension have a
more pronounced pelvic floor weakness than women
with primary stress urinary incontinence [10]. This sug-
gests that the recurrent urinary incontinence is caused
by a progression of pelvic floor dysfunction. Severe alter-
ation in the levator ani integrity is associated also with
fecal incontinence [11–13].
Histologic and histochemical analysis of pubococcygeal
muscle obtained from asymptomatic women and from
women with PFD has shown that both age and parity
(vaginal delivery) appeared to be related to the morpho-
logical features of the samples. In the symptomatic wom-
en there was a significant increase in the number of
muscle fibers showing pathological damage. The range of
diameters of both type I and II fibers was significantly
different between symptomatic and asymptomatic wom-
en. A significant proportion (90–100%) of muscle fibers
in symptomatic women were type I fibers, showed cen-
trally located nuclei, and exhibited significantly greater
diameter than type I fibers in asymptomatic women [3].
However, the cellular and molecular aspects of regres-
sion of type II fibers are poorly understood. Though ap-
optosis in adult muscles has been described, and may
result from changes within bcl2/bax system, alteration
in pathways that regulate differentiation of muscle cells,
changes in the myonuclei, and the nature of pathways in-
ducing senescence of skeletal muscles are still far from
being clear [14].
Among cell cycle related proteins, an important role in
the regulation of skeletal muscle differentiation belongs
to p27kip1 (p27) protein [15], a cyclin-dependent kinase
inhibitor required for cell cycle arrest. Additionally, since
the identification and cloning of the p27 gene in 1994
[16], the p27 protein has been shown to be involved in
various other aspects of cell physiology and pathology
[17]. Our previous study has shown, that differentiation
of cells in tissue culture is associated with an increase in
p27 expression [18]. Although a regular p27 expression
protects normal cells from apoptosis, overexpression of
p27 induces apoptosis of cells, through elevation of proa-
poptotic proteins, such as Bax [19,20]. These observa-
tions indicate that changes in p27 expression can
determine the fate of muscle cells.
Aims of the present study were to investigate p27 expres-
sion in levator ani muscle of symptomatic women, deter-
mine changes with age, and compare the p27 expression
with histochemical detection of fast- and slow twitch
muscle fibers in parallel sections. Figure 1
Schematic drawing of the pelvic floor. X indicates site of
biopsy.BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
Materials and Methods
Patients
Biopsy samples 5 ×  5 ×  5 mm were collected from 22
symptomatic patients with PFD (stress urinary inconti-
nence, pelvic organ prolapse, fecal incontinence, and
overlaps; age range 38–74) without hormone replace-
ment therapy. Besides hormone replacement, also ex-
cluded from the study were patients with a history of
malignancy, endometriosis, and pelvic infections.
Tissue sampling from levator ani muscles and fascia, il-
lustrated in Fig. 1, was based on the work of Bernstein [2]
(biopsy size and site), with some modifications approved
by the Institutional Review Board. We used similar ap-
proaches to obtain the biopsy during reconstructive sur-
gery (symptomatic patients) and abdominal
hysterectomy (asymptomatic controls). The biopsy sam-
ple was always obtained from the right pubococcygeal
muscle. The biopsy was lateral (20–25 mm) to the ure-
throvesical junction and was performed midway be-
tween the urethra and arcus tendinus (white line). It was
lateral enough from the urethra to avoid any alteration of
nerves to the urethra and bladder.
In reconstructive surgery, on entering the space of Retz-
ius, the fat was pushed aside to expose the superior fascia
of the levator ani. After incision, the fascia biopsy speci-
men (5 ×  5 mm) was collected. Next, the Allis clamp was
used to expose a small part of the pubococcygeal muscle
and collect a 5 ×  5 ×  5 mm muscle biopsy specimen.
For comparison, biopsies were obtained from nine
asymptomatic women (age 31–49) who were having a
hysterectomy for benign conditions such as abnormal
uterine bleeding, fibroids or pelvic pain, and no hormone
replacement therapy. They did not have any demonstra-
ble pelvic relaxation by examination or history of stress
urinary incontinence. We were unable, during a two year
period, collect biopsies from asymptomatic women of
age 50 or older. The apparent reason for this is that, ex-
cept for urogynecological indications and cancer, there is
virtually no reason for abdominal gynecologic surgery in
postmenopausal women. To ensure the compatibility of
biopsy samples, the space of Retzius was opened in all
patients.
During abdominal hysterectomy, the urinary bladder
was pushed down to reach the space of Retzius by inci-
sion right behind the pubic bone. The fat was pushed
aside with the assistance of a hand in the vagina, and bi-
opsy was performed as described. After biopsy, a single
figure-of-eight stitch suture was placed in all patients,
which corrected any potential loss of support that might
be caused by the biopsy. This was bloodless and did not
create any lasting difficulties. None of the control pa-
tients developed urinary incontinence or evidence of loss
of support or voiding difficulties.
In younger asymptomatic women, we also collected bi-
opsy samples of ectocervix and endometrium from hys-
terectomy specimens. These samples were utilized to
determine p27 expression in other tissues, for compari-
son with expression in the skeletal muscle (Fig. 9). In ad-
dition, we utilized our collection of frozen human
corpora lutea (CL), from which some observations have
been reported previously [21–23], in order to determine
a relationship of p27 expression with some other cell cy-
cle related proteins under specific circumstances (Fig.
10). All parts of the study were approved by the Institu-
tional Review Board at our University of Tennessee
Graduate School of Medicine. All women underwent the
informed consent process and signed informed consent
forms before participation.
Immunohistochemistry
Biopsy samples were mounted in 10 ×  10 ×  5 mm vinyl
specimen molds (Tissue-Tek Cryomold Biopsy, Miles
Inc. Diagnostic Division, Elkhart, IN) and embedded in
O.C.T. compound (Miles). The molds with specimens
were frozen in liquid nitrogen and stored at -80°C until
use. Frozen tissues were sliced into 7 µm serial sections
using a cryostat microtome with specimen retraction
during return travel (Carl Zeiss Microm HM 505 E; MI-
CROM Laborgeräte GmbH, Waldorf, Germany). The
slides were dried overnight at room temperature and
stored at 4°C. The immunohistochemical and histo-
Figure 2
A) Western blot of lysates from whole placenta (WP), tro-
phoblast culture (TrC), rectus fascia (RF), and levator ani
muscle of the symptomatic (sLM) and asymptomatic woman
(aLM). Note a single band detected by p27 monoclonal anti-
body (lanes 1–5) and a lack of nonspecific staining (lanes 6
and 7). B) Quantitative evaluation of panel A showed signifi-
cant differences in the density of p27 expression between all
measurements (P < 0.001), but not WP vs. RF (P > 0.05) and
sLM vs. aLM (P > 0.05).BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
Figure 3
p27 expression (brown color) in asymptomatic (af) and symptomatic females (sf) at the ages indicated. Dashed boxes indicate
areas shown in detail. A) Muscle fibers distant from the levator ani fascia show no cytoplasmic p27 expression. Inset shows
strong staining of plasma membrane and adjacent nucleus (arrow). B) Some fibers adjacent to the levator fascia (If) often show
weak cytoplasmic staining, but normal cell size (n). C) Hypertrophy of muscle fibers (h) is accompanied by variable p27 cyto-
plasmic expression (from none to moderate). D) Variable size of muscle fibers. Strong cytoplasmic staining accompanies
regression of myotubes (arrow and dashed box). E) Regression of muscle fibers (arrows) is associated with cytoplasmic vacu-
olization (arrowheads in inset) and expanded stromal component (s). F) Expanded muscular stroma (s) contains remnants of
muscle fibers (arrows). Inset shows control staining (cs). Bars in insets: vertical = 10 µm, horizontal = 50 µm.BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
chemical procedures were performed within two weeks.
If required, additional sections were obtained from fro-
zen blocks.
The labeled streptavidin-biotin method was employed
for peroxidase immunohistochemistry. All steps were
performed at room temperature. Universal DAKO
LSAB®2 Peroxidase Kit (DAKO Corporation, Carpinte-
ria, CA) was used according to the instructions provided
by vendor with some modifications. Briefly, cryostat sec-
tions were fixed with acetone, dried for 30 minutes, and
rinsed in phosphate buffered saline (PBS). Phosphate
buffered saline was freshly prepared before staining
from frozen 10×  stock solution, and pH adjusted to 7.22.
Mouse primary antibody, negative control reagent (DA-
KO), or PBS were applied for 15 minutes. Slides were
washed twice in PBS, and link solution (biotinated anti-
mouse antibody) was applied for 15 minutes. Subse-
quently, washed slides were incubated with streptavidin-
peroxidase conjugate for 15 minutes, washed again, and
incubated 5 minutes in substrate-chromogen solution,
rinsed with PBS, washed in distilled water, counter-
stained 2 minutes with Harris hematoxylin diluted 1:20,
dehydrated, and mounted.
Purified mouse monoclonal antibody to p27 cell cycle in-
hibitor protein, clone G173-524, was purchased from
PharMingen, San Diego, CA, and used at dilution 1:50.
This antibody shows a single band in western blots (Fig.
2). Other primary antibodies used in some instances
(Fig. 10) were mouse monoclonal antibodies to cyclin D1
(cD1, clone DCS-6, diluted 1:20, NeoMarkers, Fremont,
CA), cyclin E (cE, HE111, 1:40, Santa Cruz Biotechnolo-
gy, Santa Cruz, CA), Ki67 (Ki-67, 1:50, Dako Corpora-
tion, Carpinteria, CA), p21Cip1/WAF1 (p21, clone 70, 1:25,
Transduction Laboratories, San Diego, CA), and retino-
blastoma protein (pRb, 05–218, 1:50, Upstate Biotech-
nology, Lake Placid, NY).
Histochemistry
To determine a character of muscle fibers (type II or type
I) exhibiting changes in p27 expression, adjacent cryo-
stat sections were stained for actomyosin adenosinetri-
phosphatase (ATPase). The procedure for the
histochemical demonstration of actomyosin ATPase was
employed as described by Goth and Samara [24]. Briefly,
fixed sections were washed in rinse solution [18 mM cal-
cium chloride in 100 mM tris (hydroxymethyl) ami-
nomethane (Tris), pH 7.8] for 1 minute, preincubated
either in 50 mM potassium acetate in 18 mM calcium
chloride at pH 4.35 (for acid-stable myosin ATPase, type
I slow twitch muscle fibers), or in 18 mM calcium chlo-
ride in 100 mM 2-amino-2-methyl-1-propanol at pH
10.4 (for alkali-stable myosin ATPase, type II fast twitch
fibers). All sections were washed in rinse solution, then
incubated at 37°C in solution containing 2.7 mM ATP, 50
mM potassium chloride and 18 mM calcium chloride in
100 mM 2-amino-2-methyl-1-propanol at pH 9.4 for 30
minutes, and washed in 1% calcium chloride. The sec-
tions were placed in 2% cobalt chloride solution for 3
minutes, washed in four 30-sec changes in 100 mM 2-
amino-2-methyl-1-propanol at pH 9.4, developed in 1%
ammonium sulfide solution for 3 minutes, washed in
running tap water for 5 minutes, dehydrated in graded
Figure 4
Type II fast- (A) and type I slow twitch fibers (B), and p27
expression (C) in levator ani muscle of an asymptomatic
patient (age 38). A) Fast twitch fibers (f, dark color) alternate
with slow twitch fibers (s). B) Parallel section to (A) shows
staining of slow twitch fibers. C) Protein p27 is strongly
expressed in plasma membrane and adjacent nuclei (arrow-
heads). Note a lack of cytoplasmic staining.BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
Figure 5
Type II (A, D) and type I staining (B, E) and p27 expression (C, F) in levator ani muscle of a symptomatic patient (age 50). A-C)
Parallel sections. Fast twitch fibers (f) show type II staining only; slow twitch fibers (s) show type I staining only. Some fibers
(t1) show strong type II but also weak to moderate type I staining, without cytoplasmic p27 expression. Other fibers (t3)
exhibit no type II, strong type I and moderate p27 staining. D-F) Parallel sections. Another type of fibers (t2) shows moderate
type II and strong type I staining accompanied by moderate p27 expression, t1-t3 indicates a presumptive course of the type II
to type I transition. Arrows indicate vessels, which show both type II and type I staining and no p27 expression.BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
ethanol, cleared in xylene and mounted in Canada bal-
sam. All chemicals were obtained from Sigma Chemical
Co., St Louis, MO.
Western blots
For preparation of protein lysates from tissue samples
(levator ani muscle; rectus fascia = ~negative control;
and whole placenta = low p27 positive control) 100 tissue
sections (7 µm thick) were collected into microcentrifuge
tubes and lysed by adding ice-cold lysis buffer (20 mM
Tris pH 7.5,200 mM NaCI, 0.25% Nonidet P-40) con-
taining 1 mM sodium orthovanadate, 10 mM sodium flu-
oride, and 1 mM phenylmethylsulfonyl fluoride (400 µl/
100 mg of tissue sections). After 15 min on ice, the lysates
were sonicated by Sonicator™ Cell Disruptor (Heat Sys-
tems-Ultrasonic, Inc., Plainview, NY) for 5 seconds, and
centrifuged at 11000 ×  g for 10 min at 4°C. Supernatants
were stored at -80°C. We also prepared cell lysates from
primary trophoblast cultures (= high p27 positive con-
trol), which were established and processed as described
previously [18].
Protein concentrations were determined by Bradford as-
say (Bio-Rad, Hercules, CA). Equal amounts of protein
(21 µg; without boiling) were loaded onto reducing 10%
SDS-Tris-glycine polyacrylamide gels and transferred to
nitrocellulose (Bio-Rad). For this study, the first five
lanes were loaded with following lysates: Lane 1 = whole
placenta (WP, Fig. 2), lane 2 = trophoblast cultured for
120 hours (TrC) and derived from the placenta loaded in
lane 1, lane 3 = rectus fascia (RF), lane 4 = levator muscle
from symptomatic female, age 63 (sLM), and lane 5 = le-
vator muscle from asymptomatic female (aLM). Remain-
ing 5 lanes were loaded with molecular weight markers,
and sLM, aLM, TrC and WP lysates. After transfer, the
membrane was cut in two pieces, just in the front of the
molecular weight markers. Membranes were washed in
Tris-buffered saline containing 0.05% Tween 20 (TBST)
and non-specific binding sites were blocked by immers-
ing the membrane in blocking reagent (0.5 % casein in
TBST) for 1 hour at room temperature on an orbital shak-
er. After blocking, the membranes were briefly rinsed in
two changes of TBST, and washed once for 15 minutes
and twice for 5 minutes in fresh changes of TBST. Mem-
brane with first five lanes was stained for p27 (0.1 µg/ml
in blocking reagent, clone G173-524, PharMingen) over-
night at 4°C on an orbital shaker, followed by secondary
antibody (see below). After development and film expo-
sure, the membrane was washed and stained for actin
(0.25 µg/ml in blocking reagent, clone C4, Boehringer
Mannheim Corp., Indianapolis, IN). Remaining piece of
membrane was processed with control staining (block-
ing reagent overnight at 4°C on an orbital shaker, fol-
lowed by secondary antibody). After overnight
incubation, membranes were washed and incubated
with peroxidase labeled secondary antibody (goat anti-
mouse IgG and IgM, pre-absorbed with human serum
and diluted 1: 2000; Jackson Immunoresearch, West
Grove, PA) for 1 hour at room temperature. The mem-
branes were washed 1 ×  15 min, 2 ×  10 min and 4 ×  5 min
in fresh changes of TBST, and incubated for 1 hour in
blocking buffer at room temperature. Bound antibodies
were detected by a chemiluminescent detection system
Figure 6
Type II (A) and type I staining (B) and p27 expression (C) in
levator ani muscle of a symptomatic patient (age 63; see also
Fig. 3E). Parallel sections. A) No fast twitch fibers are evi-
dent. B) All fibers show type I staining, including those exhib-
iting gradual diminution in size (a3 and a4). C) Cytoplasmic
p27 expression gradually increases in regressing fibers (a1 to
a4). a1 to a4 indicates presumptive course of apoptosis. s,
genuine slow twitch fibers.BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
(ECL; Amersham Pharmacia Biotech, Piscataway, NJ) as
recommended by the manufacturer's protocol . For ex-
posure (first 5 min, and second up to 2 h) we used Kodak
XAR film (Eastman Kodak, Rochester, NY).
Image analysis
Evaluation was performed on a Leitz DM RB (Leica Inc.,
Wetzlar, Germany) microscope equipped with differen-
tial interference contrast and a DEI-470 CCD Video
Camera System (Optronics Engineering, Goleta, CA)
with detail enhancement. The video images were cap-
tured by CG-7 color frame grabber (Scion Corporation,
Frederick, MD) supported by Scion Image public soft-
ware developed at the National Institutes of Health
(Wayne Rasband, NIH, Bethesda, MD), and ported to
Windows 98. The pictures were copied into the Micro-
soft® PowerPoint® 97 SR-2 (Microsoft Corporation,
Redmont, WA) software, labeled, and saved in Portable
Network Graphics format.
The immunohistochemical staining was quantified as an
area in square micrometers (maximum area for whole
screen was 307,200 sq micrometers at 100×  magnifica-
tion) occupied by the densities of peroxidase staining
above the sample background, as described previously
[25,26]. Briefly, the illumination of empty field (image
background) was first adjusted to 40 in 0 to 255 scale.
Measurement of an area of peroxidase staining was per-
formed using the density slice method. The upper limit of
the density slice was set at the 255 (maximum density
value) and the lower limit at 150, sufficiently high above
the hematoxylin staining of the nuclei, which does not
exceed a density value 120. Under these conditions, the
measured area represented a crude value in square mi-
crometers (e.g., 50,000). To obtain net values, each
crude value was subtracted with the value of tissue back-
ground obtained from the same sample stained with a
control staining (e.g., 500 µm2, net value = 49,500 µm2).
Six measurements were performed on each biopsy sam-
ple. These six values represented a dataset for a single bi-
opsy (patient) stained for a particular marker. Data in
Fig. 7 represent means of 54 measurements from asymp-
tomatic patients (A; n = 9) and 132 measurements from
symptomatic patients (S; n = 22).
To evaluate the density of p27 staining in western blots,
we used a different approach. Scanned blot was trans-
ferred into the Scion Image, enlarged 4×  (two times 2× )
and each lane was processed as follows. Small square
area (20 ×  20 pixels) was used to obtain six background
measurements above the p27 band. Subsequently, six
measurements of staining within the p27 band (crude
values) were obtained. Each crude value was subtracted
with corresponding background value, giving the six net
values of p27 density. The net values were used for statis-
tical calculations.
Statistical analysis
Statistical analysis of data was performed using the Sta-
tistical Package of the Microsoft Excel 97 SR-2 (Micro-
soft Corporation, Redmont, WA) professional version
(Descriptive Statistics), and GraphPad InStat (GraphPad
Software, Inc., San Diego, CA,  [www.graphpad.com] )
software. The Mann-Whitney Test was used to compare
two columns. Repeated Measures Analysis of Variance,
followed by the posthoc Student-Newman-Keuls Multi-
ple Comparison test, was used for a comparison of mul-
tiple columns. Values of P < 0.05 were considered
significantly different. Power calculations were per-
formed using GraphPad StatMate version 1.01i (Graph-
Pad Software). A threshold P value (alpha) of 0.05, two
tailed, was selected.
Results and Discussion
Western blot analysis
Fig. 2A shows that the antibody to p27, clone G173-524,
produces a single band at 27 kDa in all investigated tis-
sues, and no nonspecific staining is apparent with sec-
ondary antibody alone. This indicates that all
Figure 7
Quantitative evaluation of p27 expression (materials and
methods) and comparison of the mean age in asymptomatic
(A) and symptomatic patients (S). ***, P < 0.0001.BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
Figure 8
Staining for p27 and type II fast twitch fibers (f-t) in the levator ani of an asymptomatic female, age 42 (af42), youngest sympto-
matic female (sf38) and the oldest asymptomatic female (af49) from our collection of cases, n, normal size fibers; h, hypertro-
phy. Details in text.BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
Figure 9
Changes of p27 expression in the epithelium of ectocervix and in endometrium during the menstrual cycle (rows show early
and mid follicular phases and mid luteal phase). A) In addition to nuclear staining (white arrow), the cytoplasmic p27 expres-
sion is apparent in the upper intermediate layers (white arrowhead) and cytoplasmic and plasma membrane staining in the sur-
face cells (black arrowhead). These two layers are divided by cells showing nuclear p27 only (dotted arrowhead). B) Cells
show only nuclear p27 throughout the epithelium. C) Strong surface expression in mature and aging epithelial cells. Note that
within cells, the traces of p27 staining are confined to the nuclear envelope (black arrow). D) Strong staining of the stroma and
patchy nuclear p27 expression in some (developing) glands (dotted arrow). E) Increased stromal and nuclear staining (vs. D).
F) p27 is severely depleted from the nuclei of glandular cells (black arrow) and stroma, but persists in vessels. Dashed line,
basement membrane; s, endometrial stroma; v, vessels.BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
Figure 10
Indirect peroxidase immunohistochemistry of mature corpus luteum of the cycle (MCL, panel A) and CL of pregnancy (CLP,
panels B-F) with monoclonal antibodies to p27, cyclin D1, cyclin E, Ki67, p21, and pRb, as indicated in panels. A) Arrowhead
indicates traces of p27 (nuclear envelope) in luteal cells of the mature CL of the cycle; note strong expression in luteal vessels.
B) Preservation of the CL during pregnancy is associated with very strong nuclear and moderate cytoplasmic expression of p27
in luteal cells, in addition to the vessels. C) Similar cytoplasmic staining of luteal cells is apparent for cyclin D1 (note unstained
vessels), but not for other cell cycle proteins investigated (panels D-F). Note that all nuclei of luteal (white arrows) and stro-
mal cells (white arrowheads) are stained in panels B and F, but only some nuclei of luteal cells are stained in panels C-E (black
arrows) and other are unstained (black arrowheads), including stroma. Insert in (D) indicates a lack of Ki67+ dividing cells in
the CL of pregnancy (and no background staining); v, luteal vessels; s, stroma.BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
immunohistochemical observations should be ascribed
to the specific expression of p27 protein. In western blot,
the most prominent p27 expression was in the late tro-
phoblast culture (120 h), as expected from our previous
study [18]. When compared to trophoblast culture, the
p27 expression in levator ani muscles was lower, but
higher then weak expression in whole placenta and rec-
tus fascia.
Fig. 2B shows quantitative evaluation (materials and
methods) of the blot in panel A. The statistical evaluation
showed no significant difference between two cases in-
cluded (symptomatic and asymptomatic female) in den-
sity of p27 expression in levator ani muscles.
Immunohistochemistry
Expression of p27 in levator ani muscle fibers of control
asymptomatic women was restricted to the plasma mem-
brane and adjacent nuclei (Fig. 3A, and inset). Some
muscle fibers close to the levator fascia often showed
weak cytoplasmic staining but no change in the cell size
(Fig. 3B). Pre- and perimenopausal symptomatic pa-
tients showed hypertrophy of muscle fibers, and this was
associated with variable cytoplasmic p27 expression,
ranging from none to moderate (Fig. 3C). Biopsy sam-
ples obtained from symptomatic women in advanced
postmenopause showed diminution of size in some fib-
ers accompanied by strong cytoplasmic p27 expression
(Fig. 3D, and inset). This was accompanied by appear-
ance of cytoplasmic vacuoles in regressing muscle fibers
(Fig. 3E, and inset) and by an increase in the stromal
component (s. Fig. 3E and 3F). Control procedure
showed no non-specific staining (inset. Fig. 3F).
These data indicate that hypertrophy of muscle fibers
may be accompanied by moderate p27 cytoplasmic ex-
pression. Further increase in cytoplasmic staining (p27
overexpression) accompanies shrinking and fragmenta-
tion of muscle fibers. This was characteristic for sympto-
matic women in advanced postmenopause, suggesting
that hormonal changes accompanying postmenopause,
such as diminution of ovarian sex steroid production,
might contribute to the degenerative changes in the leva-
tor ani muscle.
From the ovarian sex steroids, the role of diminishing es-
trogen levels is questionable, since the levator ani muscle
fibers do not express estrogen receptor alpha [2,26]. It is
not known if estrogen receptor beta is expressed, but le-
vator ani muscle fibers show nuclear expression of pro-
gesterone and androgen receptors [26]. Altered ovarian
function in the premenopause can be observed as early
as age 43 years, and includes hyperestrogenism and hy-
pergonadotropism, accompanied by decreased proges-
terone secretion [27]. During the transition from pre- to
postmenopause both estrogen and androgen levels also
decline [28]. These hormonal alterations may well be re-
sponsible for the increased gynecological morbidity that
characterizes this period of life, including structural and
molecular changes in levator ani muscle and increasing
incidence of pelvic floor disorders.
Diminution of fast twitch fibers
We also studied histochemical staining (type II and type
I fibers) along with protein p27 expression. Fig. 4, A,B,C,
is a biopsy from an asymptomatic women (age 38) exhib-
iting a proportional number of fast- (f; Fig. 4A) and slow
twitch fibers (s; Fig. 4B), and strong surface and nuclear
but no cytoplasmic p27 expression (Fig. 4C).
Fig. 5 is from a symptomatic female (age 50). Some mus-
cle fibers exhibited both type I and type II staining, rep-
resenting the "transitory" (t1 and t2) types. This was
accompanied by p27 cytoplasmic expression in t2 fibers.
In addition, some fibers showed type I staining accompa-
nied by p27 cytoplasmic expression (t3 fibers). This con-
trasted with a quiescent (genuine) fast- (f) and slow
twitch (s) fibers, which showed either type I or type II
staining and no p27 cytoplasmic expression. The "transi-
tory" fibers often exhibited hypertrophy.
Occurrence of both type II and type I staining in the same
striated muscle fiber has not been described. When using
the term "transitory" fibers, we are aware that a static
picture can not explain the dynamic process. However,
the "transitory" fibers show both type II and type I stain-
ing, cytoplasmic p27 expression suggestive of ongoing
differentiation [17,18], and marked hypertrophy. The oc-
currence of "transitory" fibers was also associated with a
decline in the number of fibers exhibiting the type II
staining only, which suggests a type II into type I transi-
tion. Also, a lack of muscle cell shrinking and fragmenta-
tion during this process indicates that type II fibers do
not degenerate but are transformed into the type I fibers.
Shrinking and fragmentation of muscle fibers
Fig. 6A shows a lack of type II fibers in postmenopausal
patient (age 63). Type I staining was characteristic for all
fibers present, including those exhibiting a diminution in
size (Fig. 6B). Staining for p27 revealed appearance of
weak (a1) to moderate cytoplasmic expression (a2) in
some otherwise normal fibers. Very strong p27 expres-
sion was characteristic for the fibers exhibiting cytoplas-
mic vacuolization (a3, see also inset, Fig. 3E) and
fragmentation (a4, arrow), i.e., morphologic features
characteristic for the cells undergoing apoptotic cell
death [29].BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
Quantitative evaluation of p27 expression
Fig. 7A shows cumulative data on p27 expression in leva-
tor ani muscle from asymptomatic and symptomatic pa-
tients. The mean p27 expression in symptomatic patients
(age range 38–73 years) was much higher (P < 0.0001)
when compared to controls (age range 31–49 years). The
power for number of cases was 80%, for number of
measurements 99%. However, there was also a highly
significant difference in mean age between the groups
(Fig. 7B; P < 0.0001, power 99%). At present, we are not
able to determine if in asymptomatic postmenopausal
women the p27 expression in levator ani muscles also in-
creases with age, since non-urogynecological surgery,
except cancer (excluded), is exceptional in such cases.
p27 cytoplasmic expression and muscle abnormality
An important question is whether the increase in cyto-
plasmic p27 expression correlates with the age of the pa-
tients and the severity of the muscle abnormality. Fig. 8
shows a lack of cytoplasmic p27 staining of levator ani
muscle in another control female (age 42, panel A) exhib-
iting normal size of muscle fibers (n) and high propor-
tion of type II fibers (panel B). Panels C and D show a
situation in the youngest patient from symptomatic
group (age 38; pelvic organ prolapse). The muscle fibers
show marked hypertrophy (h) and cytoplasmic p27 ex-
pression (panel C) associated with a lack of type II stain-
ing (panel D). On the other hand, panels E and F show a
situation in the oldest female in asymptomatic group.
The size of fibers is normal, but moderate p27 cytoplas-
mic staining is evident (panel E). This is, however, ac-
companied by a lack of fast twitch fibers (panel F).
Hence, even in the presence of moderate cytoplasmic
p27 expression in muscle fibers of normal size (Fig. 8E),
which accompanies depletion of fast twitch fibers (panel
F), the woman may remain continent, without an actual
evidence of pelvic floor disorder. On the other hand, cy-
toplasmic p27 expression accompanying hypertrophy of
muscle cells (panel C) was accompanied by PFD. These
observations indicate that an increase in cytoplasmic p27
staining may accompany normal female aging (age 49),
along with the diminution of fast twitch fibers in other-
wise normal muscles, and without manifestation of PFD.
Conversely, levator ani from younger symptomatic pa-
tient (age 38) exhibited hypertrophy of muscle cells, ac-
companied by increased cytoplasmic p27 expression and
manifestation of PFD. Altogether, the cytoplasmic p27
expression is indicative of fast to slow twitch transition of
levator ani myotubes, but not necessarily indicative of
manifestation of PFD, assuming normal muscle mor-
phology.
Table 1 summarizes our observations, and suggests pos-
sible pathways for the transition of type II to type I fibers
and progression of degeneration of levator ani muscle
cells. Note that a lack of type I staining is characteristic
for fast twitch fibers only (row 1), and a lack of p27 cyto-
plasmic expression is characteristic for the "resting" fast-
and slow twitch fibers and fibers in "early transition"
(rows 1, 2 and 5). Only fibers in row 3 show type II, type
I and p27 cytoplasmic staining, and a lack of type II
staining is apparent from row 4 on. During transition,
the fast twitch fibers may increase in size, and gradually
change into the slow twitch fibers exhibiting regular size.
Fibers in "advanced transition" (rows 3 and 4), and those
undergoing degeneration (rows 6 and 7), are associated
with cytoplasmic p27 expression. Although rows 4 and 6
are similar, the latter is associated with the regression of
many accompanying myotubes (see Fig. 3, D-F, and Fig.
6).
Table 1: Semiquantitative evaluation of the fast to slow twitch transition
Stage of muscle fiber Fiber Type II Type I Cytoplasmic Fiber size
(myotube) differentiation Typea stainingb staining p27
1 - resting fast (young) fast +++ - - normal
2 - transitory 1 trans 1 +++ ++ - normal or increased
3 - transitory 2 trans 2 ++ +++ + normal or increased
4 - transitory 3 trans 3 - +++ ++ normal or increased
5 - resting slow (mature) slow - +++ - normal
6 - early deg (aging) deg 1–2 - +++ ++ normal
7 - late deg (regressing) deg 3–4 - +++ +++ fragmented
a fast = fast twitch fibers; trans 1 = early, trans 2 = mid, trans 3 = late transition of fast- to slow twitch fibers; slow = slow twitch fibers; deg 1–2 = 
early, deg 3–4 = advanced degeneration (shrinking and fragmentation; see Fig. 3, D-F for examples, and Fig. 6 for staging). b Semiquantitative grading: 
-, none; +, weak; ++, moderate; +++, strong (see Fig. 3 to 6 for corresponding densities).BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
How unique is the unusual p27 expression for the skeletal 
muscle?
p27 is a cyclin-dependent kinase (cdk) inhibitor, and is
normally expected to be localized to the cell nucleus. In
normal cells, p27 is sequestered and its activity gradually
decreases as cells reach S phase, p27 preferentially binds
cyclin D-cdk4, but lower levels of cdk4 (in TGF-β  treated
cells) allow p27 to be available for binding to the cyclin E-
cdk2 and cyclin A-cdk2. p27 is structurally related to the
p21, having a similar sequence in the N-terminal region.
Inhibition of cell cycle by p27 and p21 is complemented
by retinoblastoma protein pRb, and other cell cycle in-
hibitors (tumor suppressor proteins) [30–32]. In reality,
besides their role in the regulation of the cell cycle, the
cdk inhibitors, in association with D-type cyclins, cyclin
E, and cdk2, play a direct role in the stimulation of epi-
thelial cell differentiation [33]. p27 is also transiently ex-
pressed in developing myotomes and enhances
myogenesis [34].
The localization of p27 to plasma membrane and the cy-
toplasm in normal and abnormal striated muscle in vivo
raises a question how unique these unusual expressions
are for the skeletal muscle cells. The observations, sum-
marized in Table 1, indicate that cytoplasmic expression
of p27 is related to two dynamic processes, (i) advanced
"transition" of fast to slow twitch fibers (rows 3 and 4,
Table 1), and (ii) gradual degeneration of muscle cells
(rows 6 and 7). On the other hand, regardless of the sta-
tus (quiescent fast and slow twitch fibers, myotubes in
transition or degenerating) the muscle cells exhibit plas-
ma membrane p27 staining.
Excellent models for the studies of cell differentiation in
vivo are stratified squamous epithelia [35], particularly
those that are easily to collect, such as the samples of ep-
ithelium of ectocervix from hysterectomy specimens. In
addition, the epithelium of ectocervix is hormonally de-
pendent, and shows certain changes along with the fluc-
tuations of levels of ovarian steroids during the
menstrual cycle. Another, even more hormonally de-
pendent tissue is endometrium. Fig. 9 shows p27 expres-
sion in the ectocervix and corresponding endometrium
(from the same uteri).
In ectocervix, during the early follicular phase, when in-
creasing levels of estrogens stimulate proliferation of
stem cells and subsequent shift of cells between the lay-
ers – toward surface, some mature epithelial cells (upper
intermediate layers) showed cytoplasmic p27 staining
(white arrowhead, Fig. 9A). p27 expression was also ap-
parent in the surface (degenerating) cells (black arrow-
head) but not between these two layers (dotted
arrowhead). This resembles the transition of type II into
type I fibers, and degeneration of myotubes. In the mid
follicular phase, p27 staining was restricted to the nuclei
(white arrow, panel B), but during the luteal phase, when
the influence of estrogens is accompanied by progester-
one, the nuclear p27 diminished (black arrow, panel C),
and mature and aged epithelial cells showed surface p27
expression, similar to that in all types of muscle fibers.
In endometrium, the early follicular phase was associat-
ed with strong stromal p27 expression (s, panel D), ac-
companied by variable nuclear expression in epithelium
of narrow glands (arrows). In the mid follicular phase,
stromal and nuclear p27 staining increased further (pan-
el E), but luteal phase endometrium showed diminution
of both (panel F). Altogether, these observations indicate
that, in addition to the striated muscle cells, the cytoplas-
mic and plasma membrane p27 expression can be ob-
served (under certain circumstances) in other cell types.
Yet, the cytoplasmic p27 expression in abnormal skeletal
muscles also appears to be temporary, i.e., during the
transition (type II to type I) and terminal regression of
myotubes.
Moreover, a combined action of estrogens and progester-
one, characteristic for the luteal phase, appears to cause
a diminution of nuclear p27 expression in the epithelium
of ectocervix and endometrium (Fig. 9, C and 9F). Curi-
ously, the remnants of p27 staining were confined to the
nuclear envelope (arrows, Fig. 9, C and 9F; see also Fig.
10A), suggesting a degradation of p27 in the nuclear core,
and/or a defect of p27 synthesis/transport. These tis-
sues, however, do posses nuclear receptors for both ster-
oids [36,37].
We did not detect similar fluctuation of nuclear p27 ex-
pression in muscle fibers, yet myotubes do not exhibit es-
trogen receptor expression [2,26]. However, estrogen,
progesterone and androgen receptors are expressed in
the principal cells (fibroblasts) of levator ani fascia [26],
which represents another important component of the
pelvic floor involved in its suspensory function, and
might be a target of the complex effect of hormonal fluc-
tuations during the cycle, and influenced by the hormone
replacement therapy in postmenopausal women.
Some recent studies indicate that long-term continuous
estrogen replacement is not beneficial, yet may worsen
or induce the manifestation of PFD [38,39], possibly
through the suppression of sex steroid receptor expres-
sion in the pelvic floor. Since progesterone and androgen
receptors are also expressed in the levator ani muscle,
and long-term estrogen replacement therapy appears to
suppress their expression [26], both the levator ani fascia
and muscle might be affected by continuous estrogen re-
placement.BMC Clinical Pathology 2001, 1:4 http://www.biomedcentral.com/1472-6890/1/4
Correlation of cytoplasmic p27 with other cell cycle pro-
teins
Cytoplasmic p27 expression in the skeletal muscle and
epithelium of ectocervix raises the question if it is associ-
ated with some other cell cycle proteins, which otherwise
show characteristic nuclear localization. We investigated
ovarian CL, another interesting structure for the studies
of cell differentiation and degeneration in vivo [21–23],
and found that cytoplasmic p27 expression is constantly
present in the CL of pregnancy.
Fig. 10, panel A, shows that the mature CL of the men-
strual cycle has p27 expression limited to the luteal ves-
sels; luteal cells show only traces of nuclear p27 (arrow)
and no cytoplasmic staining. However, in the CL of preg-
nancy, nuclei of luteal cells show abundant p27 expres-
sion (arrow, panel B), accompanied by moderate
cytoplasmic staining. Nuclear p27 is also evident in stro-
mal cells (s, arrowhead). When compared to p27, the cy-
clin D1 is expressed in some nuclei of luteal cells only
(arrow, panel C) and absent from the stromal cells in the
CL of pregnancy. However, the cytoplasmic expression of
cyclin D1 is similar to that of p27. Staining for cyclin E
(panel D) shows expression in occasional nuclei. The in-
sert shows a lack of Ki67+ dividing cells. Expression of
p21 (panel E) is similar to that of cyclin E. The pRb (panel
F) shows nuclear expression similar to that of p27, in-
cluding stromal cells, but no cytoplasmic staining of
luteal cells.
These observations indicate that cytoplasmic expression
of p27 correlates with that of cyclin D1. One may specu-
late that the cdk4 is involved, since p27 has a preferential
affinity to the cyclin D-cdk4 complex. If the cytoplasmic
p27 expression in abnormal muscle cells is accompanied
by staining for cyclin D1, remains, however, to be estab-
lished.
Conclusions
This is a first report on the p27 protein expression in nor-
mal and abnormal human striated muscle cells in vivo.
Normal muscle fibers show strong nuclear and plasma
membrane expression. Cytoplasmic p27 staining accom-
panies perimenopausal transition of type II to type I fib-
ers. In the absence of other muscle abnormalities, the
diminution of type II fibers alone is not necessarily ac-
companied by PFD. Pelvic floor disorders in perimeno-
pausal patients are associated with the hypertrophy of
muscle cells and moderate cytoplasmic p27 expression,
while PFD during advanced postmenopause are associ-
ated with shrinking and fragmentation of muscle cells
and cytoplasmic p27 overexpression. The cytoplasmic
and plasma membrane p27 expression is not unique to
the muscle cells, since it can also be detected to occur, at
least temporarily, in other cell types.
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